Understanding Neonatal Jaundice: A Perspective on Causation

Tenhunen, 1968, The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase, Proc Natl Acad Sci USA, 61, 748, 10.1073/pnas.61.2.748

Maines, 1992

McCoubrey, 1997, Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3, Eur J Biochem, 247, 725, 10.1111/j.1432-1033.1997.00725.x

Stevenson, 2006, American Pediatric Society Presidential Address 2006: science on the edge with life in the balance, Pediatr Res, 60, 630, 10.1203/01.pdr.0000242308.49575.51

Ostrander, 1982, Paired determinations of blood carboxyhemoglobin concentration and carbon monoxide excretion rate in term and preterm infants, J Lab Clin Med, 100, 745

Vreman, 1999, Validation of the Natus CO-Stat™ End Tidal Breath Analyzer in children and adults, J Clin Monit Comput, 15, 421, 10.1023/A:1009982011226

Stevenson, 1997, Carbon monoxide and bilirubin production in neonates, Pediatrics, 100, 252, 10.1542/peds.100.2.252

Stevenson, 2001, Understanding newborn jaundice, J Perinatol, 21, S21, 10.1038/sj.jp.7210628

Kaplan, 2002, Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice, Pediatrics, 110, e47, 10.1542/peds.110.4.e47

AAP, 2004, Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, Pediatrics, 114, 297, 10.1542/peds.114.1.297

Stocker, 1987, Bilirubin is an antioxidant of possible physiological importance, Science, 235, 1043, 10.1126/science.3029864

Morita, 1995, Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP, Proc Natl Acad Sci USA, 92, 1475, 10.1073/pnas.92.5.1475

Acevedo, 1998, Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy, J Clin Invest, 101, 949, 10.1172/JCI927

Otterbein, 2003, Heme oxygenase-1: unleashing the protective properties of heme, Trends Immunol, 24, 449, 10.1016/S1471-4906(03)00181-9

Brune, 1987, Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase, Mol Pharmacol, 32, 497

Chung, 2008, Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation, Methods Enzymol, 441, 329, 10.1016/S0076-6879(08)01218-4

Ryter, 2007, Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models, Novartis Found Symp, 280, 165, 10.1002/9780470059593.ch12

Ryter, 2002, Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance, Mol Cell Biochem, 234–235, 249, 10.1023/A:1015957026924

Leinders-Zufall, 1995, Regulation of cyclic nucleotide-gated channels and membrane excitability in olfactory receptor cells by carbon monoxide, J Neurophysiol, 74, 1498, 10.1152/jn.1995.74.4.1498

Prabhakar, 1995, Carbon monoxide: a role in carotid body chemoreception, Proc Natl Acad Sci USA, 92, 1994, 10.1073/pnas.92.6.1994

Vreman, 1990, In vitro generation of carbon monoxide from organic molecules and synthetic metalloporphyrins mediated by light, Dev Pharmacol Ther, 15, 112, 10.1159/000457630

Vreman, 2009, Dermal carbon monoxide excretion in neonatal rats during light exposure, Pediatr Res, 66, 66, 10.1203/PDR.0b013e3181a7be77

Vreman, 1998, Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system, Can J Physiol Pharmacol, 76, 1057, 10.1139/y98-126

Vreman, 2000, Carbon monoxide in breath, blood, and other tissues, 19

Stevenson, 1994, Bilirubin production in healthy term infants as measured by carbon monoxide in breath, Clin Chem, 40, 1934, 10.1093/clinchem/40.10.1934

Vreman, 1996, Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis, Clin Chem, 42, 50, 10.1093/clinchem/42.1.50

Vreman, 1994, Semiportable electrochemical instrument for determining carbon monoxide in breath, Clin Chem, 40, 1927, 10.1093/clinchem/40.10.1927

Stevenson, 2001, Prediction of hyperbilirubinemia in near-term and term infants, Pediatrics, 108, 31, 10.1542/peds.108.1.31

Bhutani, 1999, Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns, Pediatrics, 103, 6, 10.1542/peds.103.1.6

Stevenson, 2004, A primer on neonatal jaundice, Adv Pediatr, 51, 263, 10.1016/S0065-3101(23)00042-7

Stevenson, 2002, The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia, Minerva Pediatr, 54, 373

Maines, 1981, Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat, Biochim Biophys Acta, 673, 339, 10.1016/0304-4165(81)90465-7

Stevenson, 1989, The use of metalloporphyrins for the chemoprevention of neonatal jaundice, Am J Dis Child, 143, 353

Vreman, 2001, Alternative metalloporphyrins for the treatment of neonatal jaundice, J Perinatol, 21, S108, 10.1038/sj.jp.7210645

Wong, 2007, Tin mesoporphyrin for the prevention of severe neonatal hyperbilirubinemia, Neoreviews, 8, e77, 10.1542/neo.8-2-e77

Vreman, 1991, In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG, Am J Med Sci, 302, 335, 10.1097/00000441-199112000-00002

Appleton, 1999, Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations, Drug Metab Dispos, 27, 1214

Abate, 2007, The role of Bach1 in the induction of heme oxygenase by tin mesoporphyrin, Biochem Biophys Res Commun, 354, 757, 10.1016/j.bbrc.2007.01.050

Hajdena-Dawson, 2003, Effects of metalloporphyrins on heme oxygenase-1 transcription: correlative cell culture assays guide in vivo imaging, Mol Imaging, 2, 138, 10.1162/153535003322556886

Morioka, 2006, Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice, Pediatr Res, 59, 667, 10.1203/01.pdr.0000215088.71481.a6

Morisawa, 2008, Inhibition of heme oxygenase activity in newborn mice by azalanstat, Can J Physiol Pharmacol, 86, 651, 10.1139/Y08-069

Zhang, 2002, Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1, J Mol Med, 80, 655, 10.1007/s00109-002-0375-x

Zhang, 2001, Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression, Transgenic Res, 10, 423, 10.1023/A:1012042506002

Morisawa, 2008, Inhibition of heme oxygenase activity by chromium mesoporphyrin in the heme-loaded newborn mouse, E-PAS2008, 6130.9

Kaplan, 2008, Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate, J Perinatol, 28, 306, 10.1038/sj.jp.7211919

Kaplan, 2001, Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus-normal neonates, Pediatr Res, 50, 532, 10.1203/00006450-200110000-00018

Kaplan, 2007, (TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates, Pediatr Res, 61, 727, 10.1203/pdr.0b013e31805365c5

Kaplan, 2002, Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism, Hepatology, 35, 905, 10.1053/jhep.2002.32526

Kaplan, 1997, Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia, Proc Natl Acad Sci USA, 94, 12128, 10.1073/pnas.94.22.12128

Berardi, 2006, Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism, Biol Neonate, 90, 243, 10.1159/000093668

Watchko, 2006, Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns, Neuromolecular Med, 8, 513, 10.1385/NMM:8:4:513

Lin, 2008, Coexpression of gene polymorphisms involved in bilirubin production and metabolism, Pediatrics, 122, e156, 10.1542/peds.2007-3249